What better use of my Sunday afternoon then to read through all of GK's blogs. I must say Veyonda is giving me more and more hope that it will be the next blockbuster drug. I think one have to believe GK's conviction as he has been through the whole experience himself... complete ascorpal response, a 1 in 10 million phenomenon.
https://www.noxopharm.com/site/blog/an-investment-in-biotech--part-2
Ann: Publications Positive Review of Veyonda in Chemotherapy, page-10
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 14.0¢ | 11.0¢ | $559.0K | 4.481M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6612 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 99714 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |